Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dabigatran Following Transient Ischemic Attack and Minor Stroke

NCT02295826 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02295826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02295826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dabigatran Following Transient Ischemic Attack and Minor Stroke
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
December 18, 2018
Enrollment
300 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

minor ischemic stroke, transient ischemic attack